日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Atorvastatin and telmisartan do not reduce nasopharyngeal carriage of SARS-CoV-2 in mild or moderate COVID-19 in a phase IIb randomized controlled trial

在一项 IIb 期随机对照试验中,阿托伐他汀和替米沙坦并不能降低轻度或中度 COVID-19 患者鼻咽部 SARS-CoV-2 的携带率。

Bonnet, Fabrice; Doumbia, Adama; Machault, Vanessa; Ello, Frederic Nogbou; Bellecave, Pantxika; Akpovo, Corine Bernice; Sidibe, Baba Toumany; Fernandez, Laura; Kouamé, Antoine; Adjogoua, Edgard; Dosso, Mireille; Niangoran, Serge; Journot, Valérie; Eholié, Serge Paul

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

接受多替拉韦类抗逆转录病毒疗法患者的HIV-1耐药性:一项合作队列分析

Loosli, Tom; Hossmann, Stefanie; Ingle, Suzanne M; Okhai, Hajra; Kusejko, Katharina; Mouton, Johannes; Bellecave, Pantxika; van Sighem, Ard; Stecher, Melanie; d'Arminio Monforte, Antonella; Gill, M John; Sabin, Caroline A; Maartens, Gary; Günthard, Huldrych F; Sterne, Jonathan A C; Lessells, Richard; Egger, Matthias; Kouyos, Roger D

Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms

法国1992年至2016年朊病毒病25年前瞻性监测:疫情缓慢减弱,散发病例增多

Denouel, Angéline; Brandel, Jean-Philippe; Peckeu-Abboud, Laurène; Seilhean, Danielle; Bouaziz-Amar, Elodie; Quadrio, Isabelle; Oudart, Jean-Baptiste; Lehmann, Sylvain; Bellecave, Pantxika; Laplanche, Jean-Louis; Haik, Stéphane

One year of SARS-CoV-2 circulation in the Nouvelle-Aquitaine region, February 2021-2022, France

2021 年 2 月至 2022 年 2 月,法国新阿基坦大区 SARS-CoV-2 传播一年情况

Luc Deroche, Pantxika Bellecave, Romain David, Eric Ouattara, Magali Garcia, France Roblot, Laurence Boinot, Jean-François Faucher, Aurélie Rejasse, Guillaume Gschwind, Denis Malvy, Laurent Filleul, Sylvie Rogez, Nicolas Lévêque, Marie-Edith Lafon

sHIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies

接受多替拉韦抗逆转录病毒疗法治疗的患者中sHIV-1耐药性的发生:队列研究的合作分析

Loosli, Tom; Hossmann, Stefanie; Ingle, Suzanne M; Okhai, Hajra; Kusejko, Katharina; Mouton, Johannes; Bellecave, Pantxika; van Sighem, Ard; Stecher, Melanie; d'Arminio Monforte, Antonella; Gill, M John; Sabin, Caroline A; Maartens, Gary; Günthard, Huldrych F; Sterne, Jonathan A C; Lessells, Richard; Egger, Matthias; Kouyos, Roger

Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia

康复者血浆疗法治疗持续存在SARS-CoV-2病毒血症的重症COVID-19患者的可行性

Camou, Fabrice; Tinevez, Claire; Beguet-Yachine, Mathilde; Bellecave, Pantxika; Ratiarison, Diana; Tumiotto, Camille; Lafarge, Xavier; Guisset, Olivier; Mourissoux, Gaëlle; Lafon, Marie-Edith; Bonnet, Fabrice; Issa, Nahéma

New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017

2013年至2017年法国,新型HIV-1循环重组形式94:从大型传播集群的系统发育检测到地理社交网络应用程序时代的预防

Wirden, Marc; De Oliveira, Fabienne; Bouvier-Alias, Magali; Lambert-Niclot, Sidonie; Chaix, Marie-Laure; Raymond, Stéphanie; Si-Mohammed, Ali; Alloui, Chakib; André-Garnier, Elisabeth; Bellecave, Pantxika; Malve, Brice; Mirand, Audrey; Pallier, Coralie; Poveda, Jean-Dominique; Rabenja, Theresa; Schneider, Veronique; Signori-Schmuck, Anne; Stefic, Karl; Calvez, Vincent; Descamps, Diane; Plantier, Jean-Christophe; Marcelin, Anne-Genevieve; Visseaux, Benoit

Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles

Provir/Latitude 45 研究:基于存档的 HIV-1 DNA 和主要 HLA I 等位基因设计的多表位 CTL 疫苗的研发进展

Tumiotto, Camille; Alves, Bruna M; Recordon-Pinson, Patricia; Jourdain, Marine; Bellecave, Pantxika; Guidicelli, Gwenda-Line; Visentin, Jonathan; Bonnet, Fabrice; Hessamfar, Mojdan; Neau, Didier; Sanchez, Jorge; Brander, Christian; Sajadi, Mohammad; Eyzaguirre, Lindsay; Soares, Esmeralda A; Routy, Jean-Pierre; Soares, Marcelo A; Fleury, Hervé

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

人类免疫缺陷病毒1型少数变异株对利匹韦林一线治疗方案病毒反应的影响

Raymond, Stéphanie; Nicot, Florence; Pallier, Coralie; Bellecave, Pantxika; Maillard, Anne; Trabaud, Mary Anne; Morand-Joubert, Laurence; Rodallec, Audrey; Amiel, Corinne; Mourez, Thomas; Bocket, Laurence; Beby-Defaux, Agnès; Bouvier-Alias, Magali; Lambert-Niclot, Sidonie; Charpentier, Charlotte; Malve, Brice; Mirand, Audrey; Dina, Julia; Le Guillou-Guillemette, Hélène; Marque-Juillet, Stéphanie; Signori-Schmuck, Anne; Barin, Francis; Si-Mohamed, Ali; Avettand Fenoel, Véronique; Roussel, Catherine; Calvez, Vincent; Saune, Karine; Marcelin, Anne Geneviève; Rodriguez, Christophe; Descamps, Diane; Izopet, Jacques

GCN2 phosphorylates HIV-1 integrase and decreases HIV-1 replication by limiting viral integration

GCN2 磷酸化 HIV-1 整合酶,通过限制病毒整合来减少 HIV-1 复制

A Jaspart, C Calmels, O Cosnefroy, P Bellecave, P Pinson, S Claverol, V Guyonnet-Dupérat, B Dartigues, M S Benleulmi, E Mauro, P A Gretteau, V Parissi, M Métifiot, M L Andreola1